Royal Bank Of Canada Obs Eva Sa Transaction History

Royal Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.34 - $2.08 $1 - $2	1 New	1 $0
Q1 2022 May 16, 2022	SELL	$1.1 - $2.17 $2 - $4	-2 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.99 - $3.1 $1,751 - $2,728	-880 Reduced 99.77%	2 $0
Q2 2021 Aug 16, 2021	BUY	$2.56 - $3.35 $2,257 - $2,954	882 New	882 $3,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.